Read our COVID-19 research and news.


Putting secondary antibodies first

Jackson ImmunoResearch


The increasing complexity of immuno-oncology experiments and the expanding development of treatments drive the need for even more commercially available reagents that scientists can trust. While primary antibodies usually get the most attention from researchers, secondary antibodies are often crucial for the success of an experiment. From basic research in immuno-oncology to diagnostics and treatments, secondary antibodies improve imaging and flow-based work. In supporting immuno-oncology, Jackson ImmunoResearch provides a wide range of secondary antibodies and their respective reporter conjugates.


Custom Publishing

Read all of the best Custom Publishing content from Science. Visit our Custom Publishing section for special collections, tech features, posters and more.

Custom Publishing